Tag Archives: NASDAQ:BRKR

A Director at Bruker (NASDAQ: BRKR) is Buying Shares

Today, a Director at Bruker (BRKR – Research Report), Gilles Gerard Jean Martin, bought shares of BRKR for $1.16M. In addition to Gilles Gerard Jean Martin, 2 other BRKR executives reported Buy trades in the last month. See today’s analyst

Bruker (BRKR) Receives a Hold from Needham

In a report released today, Stephen Unger from Needham maintained a Hold rating on Bruker (BRKR – Research Report). The company’s shares closed last Tuesday at $37.95. According to TipRanks.com, Unger is a 5-star analyst with an average return of

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bruker (NASDAQ: BRKR) and Immunomedics (NASDAQ: IMMU)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bruker (BRKR – Research Report) and Immunomedics (IMMU – Research Report). Bruker (BRKR) Needham analyst Stephen Unger assigned a Hold rating to Bruker

The CEO & President of Bruker is Exercising Options

Yesterday it was reported that the CEO & President of Bruker (BRKR – Research Report), Frank Laukien, exercised options to buy 25,000 BRKR shares at $24.40 a share, for a total transaction value of $610K. See today’s analyst top recommended

Bruker (BRKR) Gets a Buy Rating from Needham

In a report issued on December 20, Stephen Unger from Needham maintained a Buy rating on Bruker (BRKR – Research Report), with a price target of $62.00. The company’s shares closed last Monday at $51.61, close to its 52-week high

A Director at Bruker is Exercising Options

Yesterday it was reported that a Director at Bruker (BRKR – Research Report), Richard Packer, exercised options to sell 18,000 BRKR shares at $13.78 a share, for a total transaction value of $885.1K. The options were close to expired and